A REVIEW OF ANTI-HYPERTENSION THERAPIES IN DIABETIC PATIENTS
Journal Title: Journal of Basic and Clinical Pharmacy - Year 2010, Vol 1, Issue 3
Abstract
The objective of this study was to review published articles on the issues surrounding tight blood pressure control in hypertensive diabetics.Relevant medical subject headings (MeSH) terms and keywords to review scientific literatures were developed. These MeSH terms were used to generate MEDLINE searches that focused on English-language, peer-reviewed scientific literature.In reviewing the exceptionally large body of research literature in anti-hypertension therapies in diabetic patients , the review focused on outcomes of importance to patients and effects of sufficient magnitude to warrant changes in medical practice (“patient oriented evidence that matters” [POEMs]).Patient-oriented outcomes include not only mortality but also other outcomes that affect patients’ lives and well-being. Studies of physiological end points (diseaseoriented evidence [DOEs]) were used to address questions where POEMs were not available.Treatment of hypertension in diabetic patients provides dramatic beneficial outcomes.Target diastolic BP of < 80 mmHg appears optimal; and systolic targets of 130mmHg or less are also reasonable. Studies that compare drug classes do not suggest obviously superior agents. However, it is reasonable to conclude that ACEIs, thiazide diuretics and angiotension II receptor blockers may be the preferred first-line agents for treatment of hypertension in diabetes. ACEIs, ARBs and low dose thiazide diuretics may be the first line treatments although other agents are usually necessary and goals may not be achieved even with three or four agents. Aggressive blood pressure control may be the most important factor in preventing adverse outcomes in hypertensive patients with diabetes.
Authors and Affiliations
Adibe Ogochukwu, UKWE VICTORIA
Keywords
Related Articles
- EP ID EP119501
- DOI -
- Views 111
- Downloads 0
Therapeutic Drug Monitoring By Reverse Iontophoresis
Therapeutic molecules possessing distinct pharmacokinetic variation, narrow therapeutic index and concentration dependent therapeutic/adverse effects demand constant monitoring. The current methods for blood sampling are...
Safety Aspects of Antiretroviral Therapy for Management of HIV Infection
There are four classes of antiretroviral agents used in the treatment of HIV/AIDS. Adverse effects to Highly Active Antiretroviral Therapy (HAART ) are common and often difficult to avoid. In many cases, research is not...
Development of Chicken Egg Yolk Antibodies against Streptococcus mitis – Purification and Neutralizing Efficacy
Chicken Egg Yolk antibodies (IgY) were raised in 24 week old white leg horn chickens against Streptococcus mitis (MTCC 2696). The chickens received Booster injections of increasing concentrations of antigen to raise the...
Extensively drug resistant tuberculosis (XDR-TB): A potential threat
Emergence of extensively drug resistant tuberculosis (XDR-TB) has been reported by more than 55 countries. XDR-TB is considered as untreatable and highly fatal disease. In developing countries like India, number of cases...
CACO-2 CELL LINES IN DRUG DISCOVERY - AN UPDATED PERSPECTIVE
Cell lines are the invitro models used for the drug permeability studies in the preclinical and clinical phases of the drug discovery. Cell line models are simple and quick to use and avoids the usage of animal models fo...